(1s,4s)-4-(6-amino-2-chloro-9H-purin-9-yl)-N-(4,4,6,6-tetramethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)cyclohexanecarboxamide

ID: ALA5094847

PubChem CID: 134214706

Max Phase: Preclinical

Molecular Formula: C22H29ClN8OS

Molecular Weight: 489.05

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)Cc2nc(NC(=O)[C@H]3CC[C@@H](n4cnc5c(N)nc(Cl)nc54)CC3)sc2C(C)(C)N1

Standard InChI:  InChI=1S/C22H29ClN8OS/c1-21(2)9-13-15(22(3,4)30-21)33-20(26-13)29-18(32)11-5-7-12(8-6-11)31-10-25-14-16(24)27-19(23)28-17(14)31/h10-12,30H,5-9H2,1-4H3,(H2,24,27,28)(H,26,29,32)/t11-,12+

Standard InChI Key:  GHFQTATWQGKKLA-TXEJJXNPSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   11.4572  -13.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1671  -13.3598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4618  -12.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7561  -12.2785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5456  -13.0709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3371  -12.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1018  -12.5783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8114  -12.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8086  -11.3462    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1000  -10.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3937  -12.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3949  -11.3529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6187  -11.0993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1377  -11.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6168  -12.4205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0962  -10.1238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3631  -13.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5643  -13.3608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3099  -14.1336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8529  -14.7448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6538  -14.5778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9117  -13.7996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5962  -15.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7960  -15.6863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.2524  -15.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1399  -16.1308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5198  -12.5764    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   14.4234  -14.2737    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.4362  -15.1532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1096  -14.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7160  -13.8652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7765  -12.8173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3365  -14.1599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
 11  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 10 16  1  0
 17 15  1  1
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  1
 23 24  1  0
 24 25  1  0
 23 26  2  0
  8 27  1  0
 25 28  1  0
 28 31  1  0
 30 29  1  0
 29 25  2  0
 30 31  2  0
 30 33  1  0
 31  5  1  0
  5 32  1  0
 32  2  1  0
  2 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5094847

    ---

Associated Targets(Human)

CHKA Tchem Choline kinase alpha (330 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHKB Tbio Choline/ethanolamine kinase (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 489.05Molecular Weight (Monoisotopic): 488.1874AlogP: 4.05#Rotatable Bonds: 3
Polar Surface Area: 123.64Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.61CX Basic pKa: 8.48CX LogP: 2.87CX LogD: 2.64
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.12

References

1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P..  (2021)  Identification of unprecedented ATP-competitive choline kinase inhibitors.,  51  [PMID:34416377] [10.1016/j.bmcl.2021.128310]

Source